Officer exercised or converted 9,532 VRTX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 6, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 8, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000875320-26-000002
Added to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerVERTEX PHARMACEUTICALS INC / MA Reporting personCharles F Jr Wagner Officer titleEVP, CO & FO TableNon-derivative (Table I) Transaction dateJan 6, 2026 Acquired / disposedAcquired (A) Around the same time
Congressional trade2 different filers disclosed VRTX within 90 days. Disclosed 4 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.